Bluejay Diagnostics
BJDX
11 hedge funds and large institutions have $129K invested in Bluejay Diagnostics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
120% more funds holding
Funds holding: 5 → 11 (+6)
9% more capital invested
Capital invested by funds: $119K → $129K (+$10.4K)
0.12% less ownership
Funds ownership: 0.15% → 0.03% (-0.12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$109K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$89.4K |
| 3 |
Renaissance Technologies
New York
|
+$49.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$22K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$12K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$8.74K |
BJDX Hedge Fund Activity: Q3 2024 in Review
11 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q3 2024, worth a combined $129K — up 8.8% from $119K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BJDX positions and 2 closed out — a net gain of 7 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $109K. The largest seller was Virtu Financial, exiting entirely with an estimated $12K sold.
- 11 institutional investors held Bluejay Diagnostics (BJDX) as of Q3 2024, up from 5 in Q2 2024.
- Funds reported $129K of Bluejay Diagnostics stock for Q3 2024, up 8.8% quarter-over-quarter.
- 9 funds opened new Bluejay Diagnostics positions in Q3 2024 and 2 closed out, a net change of +7 holders.
- The largest Bluejay Diagnostics buyer in Q3 2024 was Sabby Management, an estimated $109K added.
- The largest Bluejay Diagnostics seller in Q3 2024 was Virtu Financial, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2024.